BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31745982)

  • 1. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.
    Haas DM; Hathaway TJ; Ramsey PS
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31745982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestogens in women with threatened miscarriage or recurrent miscarriage: A meta-analysis.
    Zhao Y; D'Souza R; Gao Y; Hao Q; Kallas-Silva L; Steen JP; Guyatt G
    Acta Obstet Gynecol Scand; 2024 Mar; ():. PubMed ID: 38481031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatments for incomplete miscarriage (less than 24 weeks).
    Neilson JP; Gyte GM; Hickey M; Vazquez JC; Dou L
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007223. PubMed ID: 20091626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestational agents for treating threatened or established preterm labour.
    Su LL; Samuel M; Chong YS
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD006770. PubMed ID: 24482121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal micronised progesterone for the prevention of hypertensive disorders of pregnancy: A systematic review and meta-analysis.
    Melo P; Devall A; Shennan AH; Vatish M; Becker CM; Granne I; Papageorghiou AT; Mol BW; Coomarasamy A
    BJOG; 2024 May; 131(6):727-739. PubMed ID: 37941309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced paternal age is associated with an increased risk of spontaneous miscarriage: a systematic review and meta-analysis.
    du Fossé NA; van der Hoorn MP; van Lith JMM; le Cessie S; Lashley EELO
    Hum Reprod Update; 2020 Sep; 26(5):650-669. PubMed ID: 32358607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial.
    Kuptarak A; Phupong V
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2333929. PubMed ID: 38570191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year outcome after recurrent first trimester miscarriages: prognostic value of the past obstetric history.
    Kling C; Magez J; Hedderich J; von Otte S; Kabelitz D
    Arch Gynecol Obstet; 2016 May; 293(5):1113-23. PubMed ID: 26796678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we improve the outcome of pregnancies with low serum PAPP-A in the first trimester?
    Tsibizova V; Al-Sannan B; Fedorova A; Govorov I; Meyyazhagan A; Di Renzo GC
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2326303. PubMed ID: 38503546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a link between infertility, miscarriage, stillbirth, and premature or early menopause? Results from pooled analyses of 9 cohort studies.
    Liang C; Chung HF; Dobson AJ; Cade JE; Greenwood DC; Hayashi K; Hardy R; Kuh D; Schouw YTV; Sandin S; Weiderpass E; Mishra GD
    Am J Obstet Gynecol; 2023 Jul; 229(1):47.e1-47.e9. PubMed ID: 37059411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of tumor necrosis factor-alpha inhibitor on pregnancy outcomes in patients with unexplained recurrent miscarriage.
    Mu F; Wang C; Liu L; Zeng X; Wang F
    Immunobiology; 2024 May; 229(3):152808. PubMed ID: 38735178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infertility, recurrent pregnancy loss, and risk of stroke: pooled analysis of individual patient data of 618 851 women.
    Liang C; Chung HF; Dobson AJ; Hayashi K; van der Schouw YT; Kuh D; Hardy R; Derby CA; El Khoudary SR; Janssen I; Sandin S; Weiderpass E; Mishra GD
    BMJ; 2022 Jun; 377():e070603. PubMed ID: 35732311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation in recurrent miscarriage - a comprehensive perspective from uterine microenvironment and immune cell imbalance to therapeutic strategies.
    Lin M; Xu H; Qiu J
    Ginekol Pol; 2024; 95(4):266-275. PubMed ID: 38334340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Progesterone Deficiency in First-Trimester Miscarriage and the Impact of Hormone Therapy on Foetal Development: A Scoping Review.
    Bataa M; Abdelmessih E; Hanna F
    Children (Basel); 2024 Apr; 11(4):. PubMed ID: 38671639
    [No Abstract]   [Full Text] [Related]  

  • 15. Progesterone in Pregnancy: Evidence-Based Strategies to Reduce Miscarriage and Enhance Assisted Reproductive Technology.
    Lai TJ; Teng SW; Chang CK; Huang CY
    Med Sci Monit; 2024 Mar; 30():e943400. PubMed ID: 38501164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of miscarriage is associated with ambient temperature: evidence from coastal Bangladesh.
    Das S; Sagar S; Chowdhury S; Akter K; Haq MZ; Hanifi SMA
    Front Public Health; 2023; 11():1238275. PubMed ID: 38026421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How long after a miscarriage should women wait before becoming pregnant again? Multivariate analysis of cohort data from Matlab, Bangladesh.
    Davanzo J; Hale L; Rahman M
    BMJ Open; 2012; 2(4):. PubMed ID: 22907047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of depression and depressive symptoms in women with previous miscarriages or stillbirths - A systematic review.
    Mergl R; Quaatz SM; Lemke V; Allgaier AK
    J Psychiatr Res; 2024 Jan; 169():84-96. PubMed ID: 38006823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid improvement event: progesterone prescribing in prevention of miscarriage.
    Bolger LA; O'Riordan N; Allen C
    BMJ Open Qual; 2024 Mar; 13(1):. PubMed ID: 38531628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Administering Live Vaccines During Pregnancy: A Systematic Review and Meta-Analysis of Pregnancy Outcomes.
    Laris-González A; Bernal-Serrano D; Jarde A; Kampmann B
    Vaccines (Basel); 2020 Mar; 8(1):. PubMed ID: 32168941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.